Direct to Consumer Genetic Testing Market Size, Share Global Analysis Report, 2020–2026

Industry Insights

[179+ Pages Report] According to the report published by Facts Factors, the global direct to consumer genetic testing market size was worth around USD 714 million in 2019 and is predicted to grow to around USD 2400 million by 2026 with a compound annual growth rate (CAGR) of roughly 19% between 2020 and 2026. The report analyzes the global direct to consumer genetic testing market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the direct to consumer genetic testing market.

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Direct to Consumer Genetic Testing industry. The report analyzes and declares the historical and current trends analysis of the Direct to Consumer Genetic Testing industry and subsequently recommends the projected trends anticipated to be observed in the Direct to Consumer Genetic Testing market during the upcoming years.

The direct to consumer genetic testing market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire direct to Consumer Genetic Testing market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of and value (USD Million) from FY 2016 – 2026.

Key Insights from Primary Research

• As per our primary respondents, the direct to Consumer Genetic Testing market is set to grow annually at a rate of around 19%.
• It was established through primary research that the Direct to Consumer Genetic Testing market was valued at around USD 714million in 2019.
• After secondary research, we performed face to face interviews to validate our data. The insights interviewee’s declared that Nutrigenomics testing is the most used test type for the global Direct to Consumer Genetic Testing market.
• On the basis of the test type, Nutrigenomics testing dominated the global Direct to Consumer Genetic Testing market in 2019. It accounted for around 48% share of the total market in 2019.
• The Targeted analysis segment, on the basis of technology segmentation, was the leading revenue-generating category accounting for around 37% share, in 2019.

Key Recommendations from Analysts

• Based on the exhaustive secondary research done by our team, the Nutrigenomics testing is anticipated to become the most demanding test type in the upcoming years, owing to the growing demand for Direct to Consumer Genetic Testing from the pharmaceutical industry for various end-use applications.
• As per our analysts, North America recorded the highest market share of more than 37% by 2026, and the market is expected to bolster in this region, resulting in creating lucrative opportunities for new players.
• Growing at a CAGR around 19%, the Direct to Consumer Genetic Testing market provides numerous opportunities for all of the involved stakeholders across the entire value chain.
• Our analysts have identified Nutrigenomics testing and targeted analysis categories as the leading investment pockets for the Direct to Consumer Genetic Testing market in terms of test type and technology segmentation respectively.
• Our analysts recommend the emerging players to focus on Targeted analysis owing to the substantial growth of the pharmaceutical industry, especially in APAC and Middle-eastern regions combined with its low price and presence of huge population in those regions.

Market Attractiveness – By Type

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Direct to Consumer Genetic Testing industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the Direct to Consumer Genetic Testing industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the Direct to Consumer Genetic Testing market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the Direct to Consumer Genetic Testing industry. The Direct to Consumer Genetic Testing market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Direct to Consumer Genetic Testing sector. Key strategic developments in the Direct to Consumer Genetic Testing market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the Direct to Consumer Genetic Testing market are appropriately highlighted in the report.

The global direct to consumer genetic testing market was valued at USD 714 million in 2019 and is projected to register a CAGR of 19% over the forecast period. Technological developments have allowed us to decipher and understand the information contained in our genes at ever faster speeds and lower costs in the last century. Until recently, the primary use of this technology has been in hospital-based testing facilities. However, DTC-GT is a fast-growing and potentially lucrative industry where customers order sampling kits directly.

An autonomous and relatively simple contract makes genetic testing accessible to anyone who wants to pay for it. Genetic tests, which are delivered directly to consumers, have rapidly evolved as they give access to the genetic information of a person without the involvement of a doctor in the process. It is marketed for a number of reasons, from the concept of genetic ancestry to the prediction of the risk potential of a specific disease. Recent regulatory approvals for multiple tests have played a key role in the rapid growth of the market. In addition, the decline in the price of the genome sequencing process has resulted in a relatively minute increase in genetic testing.

The Direct to Consumer Genetic Testing market research report delivers an acute valuation and taxonomy of the Direct to Consumer Genetic Testing industry by practically splitting the market on the basis of different types, applications, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026.

Report Scope

The regional segmentation of the Direct to Consumer Genetic Testing industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the Direct to Consumer Genetic Testing industry is provided for the leading economies of the world.

The Direct to Consumer Genetic Testing market is segmented based on test type and technology.  On the basis of type segmentation, the market is classified into Carrier testing, Predictive testing, Ancestry & relationship testing, and Nutrigenomics testing. In terms of technology segmentation, the market is bifurcated into Targeted analysis, Single nucleotide, Polymorphism chips, and Whole genome sequencing.

Some of the essential players operating in the Direct to Consumer Genetic Testing market, but not restricted to include

•  Ancestry
•  EasyDNA
•  23 and Me
•  Color
•  Family Tree DNA
•  Pathway Genomics
•  Full Genomes
•  Genesis HealthCare
•  Helix
•  Karmagenes
•  Map My Genome
•  Identigene
•  Living DNA

.The taxonomy of the Direct to Consumer Genetic Testing Market by its scope and segmentation is as follows:

By Test Type Segmentation Analysis

• Carrier testing
• Predictive testing
• Ancestry & relationship testing
• Nutrigenomics testing

By Technology Segmentation Analysis

• Targeted analysis
• Single nucleotide
• Polymorphism chips
• Whole genome sequencing

By Regional Segmentation Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa